BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAgile Therapeutics Announces Results of its Pre-Submission Meeting with FDABy Nasdaq OMXApr 11, 2017, 11:00 AM UTC
BusinessAkari Therapeutics Announces FDA Fast Track Designation For CoversinBy Nasdaq OMXMar 30, 2017, 8:02 PM UTC
BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
BusinessAccelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC KitBy Nasdaq OMXFeb 24, 2017, 2:46 AM UTC
BusinessAxsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Treatment Resistant DepressionBy Nasdaq OMXFeb 14, 2017, 12:02 PM UTC
